nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A splenic lymphoma/leukemia with a spontaneous blast decrease without treatment
|
Friedrich, Chloé |
|
|
136 |
1 |
p. 148 |
artikel |
2 |
Calreticulin haploinsufficiency augments stem cell activity and is required for onset of myeloproliferative neoplasms in mice
|
Shide, Kotaro |
|
|
136 |
1 |
p. 106-118 |
artikel |
3 |
Clinical and biological implications of target occupancy in CLL treated with the BTK inhibitor acalabrutinib
|
Sun, Clare |
|
|
136 |
1 |
p. 93-105 |
artikel |
4 |
Create a healthy diet after transplant!
|
Teshima, Takanori |
|
|
136 |
1 |
p. 8-9 |
artikel |
5 |
Daratumumab plus CyBorD for patients with newly diagnosed AL amyloidosis: safety run-in results of ANDROMEDA
|
Palladini, Giovanni |
|
|
136 |
1 |
p. 71-80 |
artikel |
6 |
E2A-PBX1 functions as a coactivator for RUNX1 in acute lymphoblastic leukemia
|
Pi, Wen-Chieh |
|
|
136 |
1 |
p. 11-23 |
artikel |
7 |
Editorial Board
|
|
|
|
136 |
1 |
p. i |
artikel |
8 |
Genetics of progression from MDS to secondary leukemia
|
Menssen, Andrew J. |
|
|
136 |
1 |
p. 50-60 |
artikel |
9 |
Impact of anticoagulation prior to COVID-19 infection: a propensity score–matched cohort study
|
Tremblay, Douglas |
|
|
136 |
1 |
p. 144-147 |
artikel |
10 |
Introduction to a review series on secondary leukemia
|
Soulier, Jean |
|
|
136 |
1 |
p. 1 |
artikel |
11 |
Leukemia secondary to myeloproliferative neoplasms
|
Dunbar, Andrew J. |
|
|
136 |
1 |
p. 61-70 |
artikel |
12 |
Mitochondrial carrier homolog 2 is necessary for AML survival
|
Khan, Dilshad H. |
|
|
136 |
1 |
p. 81-92 |
artikel |
13 |
Mutant CALR functions: gains and losses
|
Prins, Daniel |
|
|
136 |
1 |
p. 6-7 |
artikel |
14 |
Occupy BTK: the key to controlling CLL
|
Thompson, Philip A. |
|
|
136 |
1 |
p. 4-6 |
artikel |
15 |
Oncogenesis by E2A-PBX1 in ALL: RUNX and more
|
Licht, Jonathan D. |
|
|
136 |
1 |
p. 3-4 |
artikel |
16 |
RBCs prevent rapid PIEZO1 inactivation and expose slow deactivation as a mechanism of dehydrated hereditary stomatocytosis
|
Evans, Elizabeth L. |
|
|
136 |
1 |
p. 140-144 |
artikel |
17 |
Secondary leukemia in patients with germline transcription factor mutations (RUNX1, GATA2, CEBPA)
|
Brown, Anna L. |
|
|
136 |
1 |
p. 24-35 |
artikel |
18 |
Secondary myelodysplastic syndrome and leukemia in acquired aplastic anemia and paroxysmal nocturnal hemoglobinuria
|
Sun, Lova |
|
|
136 |
1 |
p. 36-49 |
artikel |
19 |
The microbe-derived short-chain fatty acids butyrate and propionate are associated with protection from chronic GVHD
|
Markey, Kate A. |
|
|
136 |
1 |
p. 130-136 |
artikel |
20 |
The role of AGK in thrombocytopoiesis and possible therapeutic strategies
|
Jiang, Haojie |
|
|
136 |
1 |
p. 119-129 |
artikel |
21 |
Tocilizumab not associated with increased infection risk after CAR T-cell therapy: implications for COVID-19?
|
Frigault, Matthew J. |
|
|
136 |
1 |
p. 137-139 |
artikel |